Project Grant R42HD088317

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...

This Project Grant award from the National Institute of Mental Health (NIMH), authorized under the Mental Health Research Grants program (CFDA 93.242), is for $692,070 to adapt and pilot test a digital health HIV prevention intervention for Black heterosexual couples in New York State. The primary objectives are to: 1) Adapt an existing digital health intervention to meet the specific needs of this target population; and 2) Conduct a 6-month pilot randomized controlled trial with 60 couples to...

Grant Award Summary The University of Iowa received a $1.24 million Project Grant from the John E. Fogarty International Center under the International Research and Research Training program (CFDA 93.989) awarded September 9, 2025, with completion scheduled for August 31, 2028. This award supports the adaptation and pilot testing of a multi-level, peer-led HIV prevention and stigma reduction intervention for adolescents in Western Kenya, specifically Kakamega County. The project deliverables...

Grant Award Summary Emory University received a $744,940 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 16, 2026 through May 31, 2028. The award supports the development and evaluation of a scalable, platform-agnostic mobile health (mHealth) intervention designed to increase HIV prevention service uptake among men who have sex with men (MSM) in Peru....

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...

The PHARMA-GIRL project, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), is a $408,643 implementation science study awarded to the University of California, San Francisco on February 1, 2026, with a completion date of January 31, 2028. The project will deliver foundational research evidence evaluating how existing pharmacy-based drug distribution points in Uganda can expand...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development of a novel universal rapid test for HIV diagnosis. IGE Immunodiagnostics & Therapeutics, LLC, a minority-owned small business, will receive $294,948 to adapt their existing HIV ELISA test into a 5th generation antigen/antibody combination rapid test format. The goal is to create a simple, rapid,...

Grant Award Summary The Fogarty International Center awarded Impact Research and Development Organisation (IRDO) a $234,292 Project Grant (CFDA 93.989: International Research and Research Training) effective September 13, 2025, through August 31, 2028, to develop and pilot test a multilevel, community-based intervention addressing pre-exposure prophylaxis (PrEP) stigma among adolescent girls and young women (AGYW) ages 15–24 in western Kenya. The project deliverables include participatory...